Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the efficacy and safety of adefovir dipivoxil 10 mg with
lamivudine 100 mg in Japanese patients with compensated chronic hepatitis B over 52-week
periods.